Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-5-6
|
pubmed:abstractText |
The potential therapeutic use of peptides to activate or anergize specific T cells is seriously limited by their susceptibility to proteolytic degradation. Classically, peptides are stabilized by incorporation of non-natural modifications including main chain modifications. In the case of MHC II-restricted peptides, the peptide backbone actively participates to the interaction with the MHC molecule and hence may preclude the peptidomimetic approach. We thus investigated whether a single amide bond modification influenced the peptide capacity to bind to a MHC II molecule and to stimulate specific T cells. Twenty pseudopeptide analogs of the I-Ed binder 24-36 peptide, whose sequence was derived from a snake neurotoxin, were obtained by replacing each amide bond of the peptide central part, by either a reduced psi[CH2-NH] or N-methylated psi[CO-NMe] peptide bond. In agreement with the major interacting role played by the peptide backbone, several peptides displayed a low, if any, capacity to bind to the MHC II molecule and did not lead to T cell stimulation. However, one-third of the peptides were almost as active as the 24-36 peptide in I-Ed binding assays and one-fifth in T cell stimulation assays. Among them, two pseudopeptides displayed native-like activity. Good binders were not necessarily good at stimulating T cells, demonstrating that main chain modification also affected T cell recognition. We thus showed that a peptidomimetic approach could create a new type of MHC II ligand to control T cell responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cobra Venoms,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/I-E-antigen,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Neurotoxins,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0953-8178
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
159-66
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9533443-Animals,
pubmed-meshheading:9533443-Cobra Venoms,
pubmed-meshheading:9533443-Histocompatibility Antigens Class II,
pubmed-meshheading:9533443-Hybridomas,
pubmed-meshheading:9533443-Ligands,
pubmed-meshheading:9533443-Lymphocyte Activation,
pubmed-meshheading:9533443-Methylation,
pubmed-meshheading:9533443-Mice,
pubmed-meshheading:9533443-Neurotoxins,
pubmed-meshheading:9533443-Oxidation-Reduction,
pubmed-meshheading:9533443-Peptides,
pubmed-meshheading:9533443-Protein Binding,
pubmed-meshheading:9533443-Structure-Activity Relationship,
pubmed-meshheading:9533443-T-Lymphocytes
|
pubmed:year |
1998
|
pubmed:articleTitle |
Pseudopeptide ligands for MHC II-restricted T cells.
|
pubmed:affiliation |
Département d'Ingénierie et d'Etudes des Protéines, CEA-Saclay, Gif-sur-Yvette, France.
|
pubmed:publicationType |
Journal Article
|